Laura Kemper

🏛️ Revolving Door

Former Government Position:

Counsel, Sen. John Cornyn; Deputy Assistant Secretary for Legislation, U.S. Department of Health and Human Services; Counselor to the Secretary, U.S. Department of Health and Human Services

Share:𝕏LinkedInFacebook
🤖

AI Overview

Laura Kemper has appeared in 312 federal lobbying filings at Jeffrey J. Kimbell & Associates, INC., representing 70 clients. As a former government official, they bring insider expertise to their lobbying work — part of Washington's "revolving door."

312
Total Filings
1
Firms
70
Clients
0
Issue Areas

Firms

Jeffrey J. Kimbell & Associates, INC.0 filings

Top Clients

The Allergy, Asthma & Sinus Center0 filings
Amgen INC.0 filings
Collegium Pharmaceutical0 filings
Tennessee Rural Health Improvement Association (Fkn Tennessee Farm Br. Assn.)0 filings
Medical Device Manufacturers Association0 filings
Sparc0 filings
Genus Lifesciences0 filings
Boehringer Ingelheim Pharmaceuticals, INC.0 filings
Harmony Biosciences, LLC0 filings
Organon & Co.0 filings
Scpharmaceuticals, INC.0 filings
Supernus Pharmaceuticals INC0 filings
U.S. Renal Care0 filings
Nevro Corporation0 filings
Digital Alpha Advisors LLC0 filings
Glaukos Corporation (FKA Avedro, INC.)0 filings
Aurion Biotech0 filings
Neurotech Pharmaceuticals0 filings
Spark Therapeutics, INC.0 filings
Terumo Bct0 filings

Related Analysis

🏛️ Revolving Door Premium
Do ex-government lobbyists earn more?
🕸️ Network Analysis
Explore connections between firms and lobbyists
🎯 Market Concentration
How concentrated is the lobbying market?

Related Investigations

The Revolving Door Exposed
How former government officials become the most powerful lobbyists.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Explore More

← All Lobbyists🏛️ Revolving Door🕸️ Network Analysis🏛️ Agency Pressure 🔍 Investigations

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.